New study: app and nurse calls ease chemo side effects for cancer patients

NCT ID NCT07405931

First seen Feb 14, 2026 · Last updated May 14, 2026 · Updated 14 times

Summary

This study tests whether a digital health platform, which includes a symptom-tracking app and a nurse-led phone program, can help cancer patients better manage chemotherapy side effects. About 414 adults with early or advanced stomach, lung, breast, or colon cancer will participate. The goal is to improve quality of life and support self-management during treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gachon University Gil Medical Center

    NOT_YET_RECRUITING

    Incheon, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Gyeongsang National University

    RECRUITING

    Jinju, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kosin University Gospel Hospital

    RECRUITING

    Busan, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center, Korea

    RECRUITING

    Goyang, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ulsan University Hospital

    RECRUITING

    Ulsan, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.